neelakantan 5-amino-1mq 2018 biochemical pharmacology NNMT Inhibitor Tablets 5-Amino-1MQ Capsules 50mg (10 Vials)
Description
retatrutide carries GLP-1 class risks including nausea and pancreatitis, whilst 5-Amino-1MQ has no established human safety profile and is sold online without quality verification
They never interfere
They are the same compound
status in flux), and both are WADA-prohibited (class S2) for athletes
Instead, they bind to an allosteric site, thereby inhibiting NNMT activity
These studies used doses ranging from 1 mg per day to 30 mg per day administered through various routes (subcutaneous, oral, and intranasal)
